| View |
|
DRP-4650-02
|
Ursodeoxycholic acid
|
Lupibile
|
300 mg
|
Tablet
|
Bile Acid Derivative
|
Sydler Remedies Private Limited
|
India
|
CLIDP Conversion
|
18 May 2024
|
19 December 2025
|
| View |
|
DRP-4699-05
|
Betamethasone (as valerate)
|
Betnolyf
|
1 mg / g (0.1 % w/w)
|
Cream
|
Corticosteroid
|
Unijules Life Sciences Limited
|
India
|
CLIDP Conversion
|
18 May 2024
|
13 September 2028
|
| View |
|
DRP-4703-02
|
Finasteride
|
Prosta-One
|
5 mg
|
Film-Coated Tablet
|
Testosterone-5-Alpha Reductase Inhibitor
|
Sydler Remedies Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 May 2024
|
09 September 2028
|
| View |
|
DRP-4948-16
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pizotaz
|
4 g / 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin with Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
18 May 2024
|
22 November 2028
|
| View |
|
DRP-5025-47
|
Omeprazole (as sodium)
|
Gizol
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump (H+K+ATPase) Inhibitor
|
Shreechem Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 May 2024
|
27 December 2028
|
| View |
|
DRP-5051-05
|
Azithromycin (as dihydrate)
|
Zentrocin
|
200 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
22 May 2024
|
10 June 2028
|
| View |
|
DRP-5170-03
|
Glimepiride
|
Gliped
|
3 mg
|
Tablet
|
Blood Glucose-Lowering Drug (Sulfonylurea)
|
LifeSquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
21 May 2024
|
14 February 2029
|
| View |
|
DRP-524-06
|
Iron (as Ferrous Sulfate) + Folic Acid
|
Felizen OB
|
60 mg (equivalent to 200 mg Ferrous Sulfate)/400 mcg
|
Capsule
|
Mineral / Vitamin
|
Compact Pharmaceuticals, Corp
|
Philippines
|
CLIDP Conversion
|
16 May 2024
|
07 May 2028
|
| View |
|
DRP-5421-12
|
Telmisartan
|
Telzel
|
40mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer’s Lab. Unit II
|
India
|
Renewal
|
12 August 2024
|
24 August 2029
|
| View |
|
DRP-5676
|
Clindamycin (as phosphate)
|
Clinmed
|
150 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial
|
Norris Medicines Limited
|
India
|
Renewal
|
17 May 2024
|
29 October 2029
|
| View |
|
DRP-5909-09
|
Pantoprazole (as sodium sesquihydrate)
|
PPZ 40
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 May 2024
|
12 January 2025
|
| View |
|
DRP-6028-02
|
Rabeprazole Sodium
|
Rabegast
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Ravian Life Science Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 May 2024
|
26 February 2025
|
| View |
|
DRP-6141-02
|
Tigecycline
|
Clyntigex
|
50 mg
|
Lyophilized Powder For Injection (IV)
|
Antibacterial
|
Lyka Labs Limited
|
India
|
Renewal
|
01 July 2024
|
06 May 2030
|
| View |
|
DRP-6567-01
|
Ketoprofen
|
Fropen-S
|
30 mg
|
Plaster
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Dae Hwa Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
20 May 2024
|
09 June 2026
|
| View |
|
DRP-6812-02
|
Cetirizine Hydrochloride
|
Regizine
|
5mg/5mL
|
Syrup
|
Antihistamine
|
New Myrex Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
20 May 2024
|
26 August 2026
|
| View |
|
DRP-7257-15
|
Vitamin B1 + B6 + B12
|
Energo
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
17 May 2024
|
07 July 2027
|
| View |
|
DRP-7551-02
|
Atorvastatin (as calcium)
|
None
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
17 May 2024
|
12 May 2025
|
| View |
|
DRP-7734-09
|
Dexamethasone + Neomycin (as sulfate) + Polymyxin-B-Sulfate
|
Raypondex
|
1 mg / 3.5 mg/ 6000 IU
|
Ophthalmic & Otic Suspension
|
Corticosteroid/Anti-Infective
|
Egyptian International Pharmaceutical Industries Co
|
Egypt
|
CLIDP Conversion
|
20 May 2024
|
16 March 2028
|
| View |
|
DRP-7985-01
|
Zinc (as Zinc sulfate monohydrate)
|
Kalista OD
|
10 mg/mL
|
Syrup (Oral Drops) (Orange Flavor) Equivalent to 27.5 mg Zinc Sulfate monhydrate)
|
Mineral Supplement
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
16 May 2024
|
18 March 2028
|
| View |
|
DRP-8098-03
|
Metronidazole
|
Lexogyl
|
5 mg / mL (500 mg / 100 mL)
|
Solution for IV Infusion
|
Antiprotozoal (Nitroimidazole Derivative)
|
Unique Pharmaceutical Labs. (A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
CLIDP Conversion
|
20 May 2024
|
04 February 2025
|